The experimental coronavirus treatment remdesivir has failed in its first randomized clinical trial, inadvertently released results showed on Thursday, dampening expectations for the closely watched drug.
A draft summary went online briefly on the WHO Web site and was first reported by the Financial Times and health news Web site Stat, which posted a screenshot.
However, Gilead Sciences, the company behind the medicine, disputed how the now-deleted post had characterized the findings, saying that the data showed a “potential benefit.”
Photo: AFP
The Chinese trial involved 237 patients, with 158 on the drug and 79 in a control group, the summary said, adding that remdesivir was stopped early in 18 patients because of side effects.
The authors said that remdesivir was “not associated with a difference in time to clinical improvement” compared with the control.
After a month, 13.9 percent of the patients on remdesivir had died, compared with 12.8 percent of those in the control group. The difference is not statistically significant.
The WHO told the Financial Times that the draft is undergoing peer review and was published early in error.
“We believe the post included inappropriate characterizations of the study,” a Gilead spokesman told reporters, adding that it was terminated early due to low enrollment and was therefore not statistically meaningful.
“As such, the study results are inconclusive, though trends in the data suggest a potential benefit for remdesivir, particularly among patients treated early in disease,” the spokesman said.
The study does not represent the final word on the matter, and there are several large-scale trials in advanced stages that should soon provide a clearer picture.
Remdesivir, which is administered intravenously, was among the first drugs suggested as a treatment for the novel coronavirus and as such has great hopes riding on it.
Last week, Stat reported that it had shown significant efficacy at a Chicago hospital where patients who are part of one of the major trials are being treated.
The US National Institutes of Health also reported it that had proven effective in a small experiment on monkeys.
Remdesivir, which previously failed in trials against Ebola, belongs to a class of drugs that act on the virus directly — as opposed to controlling the abnormal and often lethal autoimmune response it causes. It mimics one of the four building blocks of RNA and DNA, and gets absorbed into the virus’ genome, which in turn stops the pathogen from replicating.
Anti-malarial drugs hydroxychloroquine and chloroquine have also been widely used on COVID-19 on a so-called “compassionate basis” pending results from large trials, with early studies decidedly mixed.
Other therapies that are being studied include collecting antibodies from COVID-19 survivors and injecting them in patients, or harvesting antibodies from genetically engineered mice that were deliberately infected.
Separately in France, new research shows that nicotine could protect people from contracting COVID-19.
The findings came after researchers at a top Paris hospital examined 343 COVID-19 patients, as well as 139 people with the illness who had milder symptoms.
They found that a low number of them smoked, compared with smoking rates of about 35 percent in France’s general population.
“Among these patients, only 5 percent were smokers,” said Zahir Amoura, the study’s coauthor and a professor of internal medicine.
The research echoed similar findings published in the New England Journal of Medicine last month suggesting that 12.6 percent of 1,000 people infected in China were smokers.
That was a much lower figure than the number of regular smokers in China’s general population, about 26 percent, WHO data showed.
The theory is that nicotine could adhere to cell receptors, therefore blocking the novel coronavirus from entering cells and spreading in the body, said neurobiologist Jean-Pierre Changeux from France’s Pasteur Institute, who also coauthored the study.
The researchers are awaiting approval from health authorities to carry out further clinical trials.
The researchers are looking into whether nicotine could help to prevent “cytokine storms,” a rapid overreaction of the immune system that scientists think could play a key role in fatal COVID-19 cases.
However, with further research needed, experts are not encouraging people to pick up smoking or use nicotine patches as a protective measure against the virus.
“We must not forget the harmful effects of nicotine,” French Director-General for Health Jerome Salomon said.
“Those who do not smoke should absolutely not use nicotine substitutes,” which cause side effects and addiction, he said.
‘UNUSUAL EVENT’: The Australian defense minister said that the Chinese navy task group was entitled to be where it was, but Australia would be watching it closely The Australian and New Zealand militaries were monitoring three Chinese warships moving unusually far south along Australia’s east coast on an unknown mission, officials said yesterday. The Australian government a week ago said that the warships had traveled through Southeast Asia and the Coral Sea, and were approaching northeast Australia. Australian Minister for Defence Richard Marles yesterday said that the Chinese ships — the Hengyang naval frigate, the Zunyi cruiser and the Weishanhu replenishment vessel — were “off the east coast of Australia.” Defense officials did not respond to a request for comment on a Financial Times report that the task group from
DEFENSE UPHEAVAL: Trump was also to remove the first woman to lead a military service, as well as the judge advocates general for the army, navy and air force US President Donald Trump on Friday fired the chairman of the Joint Chiefs of Staff, Air Force General C.Q. Brown, and pushed out five other admirals and generals in an unprecedented shake-up of US military leadership. Trump wrote in a post on Truth Social that he would nominate former lieutenant general Dan “Razin” Caine to succeed Brown, breaking with tradition by pulling someone out of retirement for the first time to become the top military officer. The president would also replace the head of the US Navy, a position held by Admiral Lisa Franchetti, the first woman to lead a military service,
Four decades after they were forced apart, US-raised Adamary Garcia and her birth mother on Saturday fell into each other’s arms at the airport in Santiago, Chile. Without speaking, they embraced tearfully: A rare reunification for one the thousands of Chileans taken from their mothers as babies and given up for adoption abroad. “The worst is over,” Edita Bizama, 64, said as she beheld her daughter for the first time since her birth 41 years ago. Garcia had flown to Santiago with four other women born in Chile and adopted in the US. Reports have estimated there were 20,000 such cases from 1950 to
CONFIDENT ON DEAL: ‘Ukraine wants a seat at the table, but wouldn’t the people of Ukraine have a say? It’s been a long time since an election, the US president said US President Donald Trump on Tuesday criticized Ukrainian President Volodymyr Zelenskiy and added that he was more confident of a deal to end the war after US-Russia talks. Trump increased pressure on Zelenskiy to hold elections and chided him for complaining about being frozen out of talks in Saudi Arabia. The US president also suggested that he could meet Russian President Vladimir Putin before the end of the month as Washington overhauls its stance toward Russia. “I’m very disappointed, I hear that they’re upset about not having a seat,” Trump told reporters at his Mar-a-Lago resort in Florida when asked about the Ukrainian
RSS